Inadequate treatment with HMG-CoA reductase inhibitors by health care providers

American Journal of Medicine

Volumn 100, Issue 6, 1996, Pages 605-610

  Marcelino, Jennifer J ^b   Feingold, Kenneth R ^a  

^a SAN FRANCISCO VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ADULT; AGED; ARTICLE; ATHEROSCLEROSIS; CHOLESTEROL BLOOD LEVEL; CLINICAL TRIAL; DATA BASE; DRUG EFFICACY; ENZYME INHIBITION; FEMALE; HEALTH CARE MANAGEMENT; HUMAN; ISCHEMIC HEART DISEASE; LIVER TOXICITY; MAJOR CLINICAL STUDY; MALE; ORAL DRUG ADMINISTRATION; PATIENT COMPLIANCE; PATIENT MONITORING; PATIENT SELECTION; PRACTICE GUIDELINE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; STATISTICAL ANALYSIS;

EID: 0030176054     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9343(96)00011-3     Document Type: Article

References (17)

1. 1. Castelli WP, Garrison RJ, Wilson PWF, et al. Incidence of coronary heart disease and lipoprotein cholesterol levels.The Framingham study. JAMA. 1986;256:2835-2838.
2. 2. Neaton JD, Blackburn H, Jacobs D, et al. Serum Cholesterol level and mortality findings for men screened in the multiple risk factor intervention trial. Arch Intern Med. 1992;152:1490-1500.
3. 3. Levine GN, Keaney JF, and Vita JA. Cholesterol reduction in cardiovascular disease. Clinical benefits and possible mechanisms. NEJM. 1995;332:512-520.
4. 4. Superko HR, and Krauss RM. Coronary artery disease regression. Convincing evidence for the benefit of aggressive lipoprotein management. Circulation. 1994;90:1056-1069.
5. 5. Scandinavian Simvastatin Survival Study Group. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet. 1994;344:1383-1389.
6. 6. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Summary of the Second Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II). JAMA. 1993;269:3015-3023.
7. 7. Grundy SM. HMG-CoA reductase inhibitors for treatment of hypercholesteremia. NEJM. 1988;319:24-32.
8. 8. Blum CB. Comparison of properties of four inhibitors of 3-Hydroxy-3-Methyglutaryl-Coenzyme A reductase. Am J Cardiol. 1994;73:3D-11D.
9. 9. Physicians' Desk Reference 1995, 49th Edition. Oradell, NJ: Medical Economics Inc. 732-735,1584-1588,1655-1658,2165-2168.
10. 10. Giles WH, Anda RF, Jones DH, et al. Recent trends in the identification and treatment of high blood cholesterol by physicians: progress and missed opportunities. JAMA. 1993;269:1133-1138.
11. 11. Cohen MV, Byrne M, Levine B, et al. Low rate of treatment of hypercholesteremia by cardiologists in patients with suspected and proven coronary artery disease. Circulation. 1991;83:1294-1304.
12. 12. Blankenhorn DH, Nessim SA, Johnson RL, et al. Beneficial effects of combined colestipol-niacin therapy on coronary atherosclerosis and coronary venous bypass grafts. JAMA. 1987;257:3233-3240.
13. 13. Brown G, Albers JJ, Fisher LD, et al. Regression of coronary artery disease as a result of intensive lipid-lowering therapy in men with high levels of apolipoprotein B.NEJM. 1990;323:1289-1298.
14. 14. Buchwald H, Varco RL, Matts JP, et al. Effect of partial ileal bypass surgery on mortality and morbidity from coronary heart disease in patients with hypercholesteremia. Report of the Program on the Surgical Control of the Hyperlipidemias (POSCH). NEJM. 1990;323:946-955.
15. 15. Kane JP, Malloy MJ, Ports TA, et al. Regression of coronary atherosclerosis during treatment of familial hypercholesteremia with combined drug regimens. JAMA. 1990;264:3007-3012.
16. 16. Sclar DA. Improving medication compliance: a review of selected issues. Clin Ther. 1991;13:436-440.
17. 17. Cramer JA, Mattson RH, Prevey ML, et al. How often is medication taken as prescribed? A novel assessment technique. JAMA. 1989;261:3273-3277.